Slow Growth Seen in Hepatitis C Market

wireframe_virus.gif

“Jefferies Sees Slower Than Expected Growth in the Hepatitis C Drug Market”

That image is a model of one of the little buggers that infected my liver.

The link below the image is to an article that, basically, looks ahead to new drug mechanisms for treating Hep C.

As too many people used to say way too often: “It’s all good”.

However, being what we, the sufferers, call a “Dragon Killer”, I’m aware of the $100,000 cost for current treatment [ I’m a Vet and “lucky” the government is paying that…].

The company that makes one of the main drugs makes a large enough profit to maintain a 24/7 hot line staffed with nurses.

I don’t wish the treatment I’m going through on future Dragon Killers and truly hope better regimens are found.

But…

With the Weird State of Mind induced by the drugs I take, a “Slow Growth Seen in Hepatitis C Market” could be remedied by CDC: Hepatitis C in Nev. could be ‘tip of iceberg’“:

“The city of Las Vegas shut down the Endoscopy Center of Southern Nevada last Friday after state health officials determined that six patients had contracted hepatitis C because of unsafe practices, including clinic staff reusing syringes and vials. Nevada health officials are trying to contact about 40,000 patients who received anesthesia by injection at the clinic between March 2004 and Jan. 11 of this year to urge them to get tested for hepatitis C, hepatitis B and HIV.”

Advertisements

2 thoughts on “Slow Growth Seen in Hepatitis C Market

  1. Its useful to realize you experience what you think about. To focus on disease invites it to say. As an alternative, its meaningful to feel grateful for your healing. Train your mind to visualize what it feels like to be fully healed. Concentrate on meditation exercises. You will be amazed by the positive effects of this approach.

  2. I stumbled across your blog and was glad I did. I am sure you are currently tracking the NOW increase in products pending release for treatment of HCV, These protease inhibitors are showing promise in late stage trials ad could be added to current therapies to help patients achieve a sustained virological response faster, and in greater numbers.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s